Form 4: CVS Health Director Mary L. Schapiro Reports Changes in Beneficial Ownership

Director Mary L. Schapiro reports acquisition of share credits for deferred compensation, increasing her holdings in CVS Health.

Summary

• On May 16, 2024, Mary L. Schapiro, a director of CVS Health Corp, acquired share credits as part of deferred compensation.
• The transaction involved the issuance of 2,912.0306 share credits at a price of $57.52 per share.
• Following the transaction, Schapiro's direct ownership of common stock increased to 11,843.9977 shares, and her derivative security holdings increased to 21,017.4328 share credits.
• These share credits are related to the deferral of a semi-annual retainer under the 2017 Incentive Compensation Plan and represent deferred stock compensation.

Sentiment

Score: 7

Explanation: Neutral sentiment as it reflects routine compensation practices and insider ownership transparency.

Positives

• The acquisition of share credits reflects ongoing participation in the company's incentive compensation plan, aligning director interests with shareholder value.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation and ownership.

Key Dates